Case Page

 

Case Status:    SETTLED
On or around 11/14/2007 (Date of order of final judgment)

Filing Date: July 02, 2004

According to the Opinion and Order signed by Judge Algenon L. Marbley on December 31, 2007, for the reasons stated herein, the Court grants Lead Counsel's request for expenses in the amount of $2,241,821.10 and grants Lead Plaintiff's request for expenses in the amount of $82,452.81. Further, it awards Class Counsel 18% of the net recovery in attorneys' fees.

On July 27, 2007, a Stipulation of Settlement was filed. On July 31, 2007, the Court entered the Order preliminarily approving the settlement. On September 17, 2007, the Lead Plaintiffs’ filed a motion for final approval of the class action settlement. On November 14, 2007, the Court entered the Order approving the Plan of Allocation and also the Final Judgment and Order of Dismissal with Prejudice.

In a press release dated May 31, 2007, Cardinal Health Inc. agreed to pay $600 million to settle a lawsuit filed by shareholders accusing the medical products and services company of accounting irregularities and inflated earnings, according to the company. In a regulatory filing on Wednesday, the company denied any wrongdoing and said it settled to eliminate the uncertainties and expense of further litigation. The settlement is subject to approval in U.S. District Court. The Medical products and services company had established a $600 million reserve for the settlement in its third quarter ended March 31.

As disclosed by the Company’s Form 10-Q For The Quarter Ended September 30, 2006, on March 27, 2006, the Court granted a Motion to Dismiss with respect to the Company’s external auditors and a former officer and denied the Motion to Dismiss with respect to the Company and the other individual defendants. On September 8, 2006, the plaintiffs filed a Motion for Class Certification. Discovery is now proceeding.

As disclosed by the same SEC filing, since July 2, 2004, 10 purported class action complaints have been filed by purported purchasers of the Company’s securities against the Company and certain of its current and former officers and directors, asserting claims under the federal securities laws (collectively referred to as the “Cardinal Health federal securities actions”). To date, all of these actions have been filed in the United States District Court for the Southern District of Ohio. On December 15, 2004, the Cardinal Health federal securities actions were consolidated into one action captioned In re Cardinal Health, Inc. Federal Securities Litigation, and on January 26, 2005, the Court appointed the Pension Fund Group as lead plaintiff in this consolidated action. On April 22, 2005, the lead plaintiff filed a consolidated amended complaint naming the Company, certain current and former officers and employees and the Company’s external auditors as defendants. The complaint seeks unspecified money damages and other unspecified relief against the defendants and includes the aforementioned Section 10(b), Rule 10b-5 and Section 20 claims.

The original complaint seeking class action status was filed against Cardinal Health, Inc. The Complaint alleges that Cardinal, and certain of its officers and directors issued materially false statements concerning the Company's financial condition. Specifically, defendants failed to disclose: (i) that Cardinal manipulated various aspects of its accounting practices to continuously portray profitability to market; (ii) that Cardinal held inventory for an average of two months, and reaped exorbitant profits from price inflation; (iii) Cardinal improperly accounted for the $22 million recovered from Vitamin makers accused of overcharging Cardinal by booking such recoveries as revenue when the antitrust cases had not been resolved; and (iv) that Cardinal's pharmaceutical distribution business improperly classified revenues by reporting the revenues as either operating revenue or revenues form bulk deliveries to consumer warehouses when revenues were not derived from such. The Complaint is on behalf of all persons who purchased the publicly traded securities of Cardinal Health, Inc. between October 24, 2000 and June 30, 2004 inclusive. Also included are all those who acquired Cardinal's shares through its acquisitions of Alaris Medical, Intercare, Medicap, Syncor, Boron Lepore, InGel, Ni-Med, SP Pharmaceuticals, or International Processing Corp. Present and former employees who purchased stock through Cardinal's Retirement Savings Plans are also included.

On June 30, 2004, Cardinal announced expected earnings per share for fiscal 2004 which were below prior guidance. Separately, the company announced that on June 21, as part of the Securities and Exchange Commission's (SEC) formal investigation disclosed by the company on May 14, it received an SEC subpoena. On this news, Cardinal fell $17.19 per share or 24.54% on July 1, 2004 to close at $52.86 per share.

COMPANY INFORMATION:

Sector: Healthcare
Industry: Biotechnology & Drugs
Headquarters: United States

SECURITIES INFORMATION:

Ticker Symbol: CAH
Company Market: New York SE
Market Status: Public (Listed)

About the Company & Securities Data


"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.

In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
COURT: S.D. Ohio
DOCKET #: 04-CV-00575
JUDGE: Hon. George C. Smith
DATE FILED: 07/02/2004
CLASS PERIOD START: 10/24/2000
CLASS PERIOD END: 06/30/2004
PLAINTIFF FIRMS NAMED IN COMPLAINT:
  1. Abbey Gardy, LLP (New York)
    212 East 39th Street, Abbey Gardy, LLP (New York), NY 10016
    212.889.3700 · info@abbeygardy.com
  2. Baron & Budd, P.C. (Dallas)
    3102 Oak Lawn Avenue, Suite 1100, Baron & Budd, P.C. (Dallas), TX 75219
    800-946-9646 · info@baronbudd.com
  3. Climaco, Wilcox, Peca, Tarantino & Garofoli Co. LPA
    55 Public Square Suite 1950, Climaco, Wilcox, Peca, Tarantino & Garofoli Co. LPA, OH 44113
    216.621.8484 · cmjani@climacolaw.com
  4. Lasky & Rifkind, Ltd.
    100 Park Avenue, Lasky & Rifkind, Ltd., NY 10017
    212.907.0800 212.684.6083 ·
  5. Law Offices of Charles J. Piven, P.A.
    World Trade Center-Baltimore,401 East Pratt Suite 2525, Law Offices of Charles J. Piven, P.A., MD 21202
    410.332.0030 · pivenlaw@erols.com
  6. Murray, Frank & Sailer LLP
    275 Madison Ave 34th Flr, Murray, Frank & Sailer LLP, NY 10016
    212.682.1818 212.682.1892 · email@murrayfrank.com
  7. Schatz & Nobel, P.C.
    330 Main Street, Schatz & Nobel, P.C., CT 06106
    800.797.5499 860.493.6290 · sn06106@AOL.com
  8. Scott & Scott LLC (Connecticut)
    P.O. Box 192, 108 Norwich Avenue, Scott & Scott LLC (Connecticut), CT 06415
    860.537.5537 860.537.4432 · scottlaw@scott-scott.com
  9. Stull, Stull & Brody (New York)
    6 East 45th Street, Stull, Stull & Brody (New York), NY 10017
    310.209.2468 310.209.2087 · SSBNY@aol.com
  10. The Emerson Firm
    2228 Cottondale Avenue, Suite 100, The Emerson Firm, AR 72202
    800.663.9817 501.907.2556 · epllp@emersonpoynter.com
  11. Weiss & Yourman (New York, NY)
    The French Building, 551 Fifth Ave., Suite 1600, Weiss & Yourman (New York, NY), NY 10126
    212.682.3025 212.682.3010 · info@wyca.com
No Document Title Filing Date
COURT: S.D. Ohio
DOCKET #: 04-CV-00575
JUDGE: Hon. George C. Smith
DATE FILED: 04/22/2005
CLASS PERIOD START: 10/24/2000
CLASS PERIOD END: 07/26/2004
PLAINTIFF FIRMS NAMED IN COMPLAINT:
  1. Cauley Bowman Carney & Williams, PLLC (Little Rock)
    11001 Executive Center Drive, Suite 200, Cauley Bowman Carney & Williams, PLLC (Little Rock), AR 72211
    501.312.8500 888.551.9944 · info@cauleybowman.com
  2. Coughlin Stoia Geller Rudman & Robbins LLP (San Diego)
    655 West Broadway, Suite 1900, Coughlin Stoia Geller Rudman & Robbins LLP (San Diego), CA 92101
    619.231.1058 619.231.7423 · info@csgrr.com/
  3. Lerach Coughlin Stoia Geller Rudman & Robbin (San Francisco)
    100 Pine Street, Suite 2600, Lerach Coughlin Stoia Geller Rudman & Robbin (San Francisco), CA 94111
    415.288.4545 415.288.4534 · info@lerachlaw.com
  4. Lerach Coughlin Stoia Geller Rudman & Robbins LLP (San Diego)
    655 West Broadway, Suite 1900, Lerach Coughlin Stoia Geller Rudman & Robbins LLP (San Diego), CA 92101
    619.231.1058 619.231.7423 ·
No Document Title Filing Date
No Document Title Filing Date